Private-payer Costs for Employees with Treatment-resistant Depression
August 18th 2016Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Read More
2 Commerce Drive
Cranbury, NJ 08512